Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02302885 · ClinicalTrials.gov registry record
Healthy Human Control Blood Collection for Validation of Biomarker Assay
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 43
- Enrollment target
NCT02302885 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 43 participants.
The verdict
NCT02302885 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
Human blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population is cancer-free 18-60 year old men and women. Volunteer selection will rely upon a short health questionnaire. About 20 mL blood will be collected from volunteers up to 20 different timepoints. The Procedure involves minimal risk of harm (eg discomfort, bruising) to the volunteer.
Interventions
- OTHER Blood collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2014-11 |
| Est. Completion | 2019-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02302885
The ClinicalTrials.gov registry entry for NCT02302885 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood collection is the first listed.
NCT02302885 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02302885 about?
NCT02302885 is a clinical study titled "Healthy Human Control Blood Collection for Validation of Biomarker Assay". Human blood will be collected to serve as control in validating clinical studies studying the detection and levels of circulating tumor cells and microvesicles in cancer patients. Targeted population is cancer-free 18-60 year old men and women. Volunteer selection will rely upon a short health quest...
What is the current status of trial NCT02302885?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2014-11. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT02302885?
The interventions under investigation include: Blood collection (OTHER).
Who is sponsoring clinical trial NCT02302885?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.